Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6,897 JPY | +0.58% |
|
+2.16% | +30.40% |
Business Summary
- manufacture and sale of pharmaceutical products (65.2% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases. In addition, the group sells diagnostic products and medical devices;
- manufacture and sale of nutraceutical products (25.1%): functional foods and beverages, OTC products, nutritional supplements;
- production of mineral waters, beverages and foods (2.1%);
- other (7.5%): manufacture of functional chemicals and fine chemicals, provision of logistics services, manufacture of electronic products, etc.
Net sales by source of income are divided between sales of products (93.8%), sales of licences and royalties (1.8%) and other (4.4%).
Net sales are distributed geographically as follows: Japan (43.2%), North America (34%),
Number of employees: 34,388
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
67.6
%
| 1,137,857 | 65.5 % | 1,364,358 | 67.6 % | +19.91% |
Nutraceuticals
23.9
%
| 437,014 | 25.1 % | 483,325 | 23.9 % | +10.60% |
Others
6.6
%
| 127,271 | 7.3 % | 133,818 | 6.6 % | +5.14% |
Consumer Products
1.8
%
| 35,854 | 2.1 % | 37,066 | 1.8 % | +3.38% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
42.2
%
| 664,607 | 38.2 % | 851,355 | 42.2 % | +28.10% |
Japan
33.2
%
| 654,662 | 37.7 % | 670,850 | 33.2 % | +2.47% |
Others
12.7
%
| 226,622 | 13.0 % | 255,673 | 12.7 % | +12.82% |
Europe
10.8
%
| 173,207 | 10.0 % | 218,667 | 10.8 % | +26.25% |
North America
1.1
%
| 18,897 | 1.1 % | 22,021 | 1.1 % | +16.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tatsuo Higuchi
CEO | Chief Executive Officer | 74 | 08-07-07 |
Yuko Makino
DFI | Director of Finance/CFO | 62 | 15-02-28 |
Ichiro Otsuka
CHM | Chairman | 59 | 08-07-07 |
Masanori Udagawa
CTO | Chief Tech/Sci/R&D Officer | - | - |
Makoto Inoue
COO | Chief Operating Officer | 65 | 20-03-26 |
Shuichi Takagi
BRD | Director/Board Member | 58 | 18-12-31 |
Yoshiro Matsuo
BRD | Director/Board Member | 63 | 08-07-07 |
Noriko Tojo
BRD | Director/Board Member | 60 | 08-08-19 |
Toshifumi Arai
IRO | Public Communications Contact | - | - |
Yuji Kogure
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tatsuo Higuchi
CEO | Chief Executive Officer | 74 | 08-07-07 |
Ichiro Otsuka
CHM | Chairman | 59 | 08-07-07 |
Yoshihisa Aoki
BRD | Director/Board Member | 72 | 19-02-28 |
Noriko Tojo
BRD | Director/Board Member | 60 | 08-08-19 |
Yoshiro Matsuo
BRD | Director/Board Member | 63 | 08-07-07 |
Makoto Inoue
COO | Chief Operating Officer | 65 | 20-03-26 |
Ko Sekiguchi
BRD | Director/Board Member | 76 | 18-02-28 |
Yukio Matsutani
BRD | Director/Board Member | 74 | 16-02-29 |
Yuko Makino
DFI | Director of Finance/CFO | 62 | 15-02-28 |
Mayo Mita
BRD | Director/Board Member | 63 | 20-02-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 557,835,617 | 454,010,353 ( 81.39 %) | 15,295,524 ( 2.742 %) | 81.39 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
15,149,500 | 2.72% | 624,123,344 $ | |
382,994,120 | 20.87% | 283,940,351 $ | |
DAIICHI SANKYO CO., LTD. 0.33% | 6,406,200 | 0.33% | 227,393,706 $ |
EARTH CORPORATION 23.18% | 5,148,000 | 23.18% | 153,806,127 $ |
NICHIBAN CO., LTD. 32.59% | 6,758,000 | 32.59% | 76,849,678 $ |
THE AWA BANK, LTD. 6.13% | 2,517,000 | 6.13% | 46,609,630 $ |
350,788 | 5.53% | 25,563,907 $ | |
DONG-A ST CO., LTD. 6.14% | 542,382 | 6.14% | 23,661,024 $ |
TBS HOLDINGS,INC. 0.59% | 1,000,000 | 0.59% | 23,373,320 $ |
EIKEN CHEMICAL CO., LTD. 3.89% | 1,500,000 | 3.89% | 20,016,540 $ |
Company contact information
Otsuka Holdings Co., Ltd.
Shinagawa Grand Central Tower, 12/F 2-16-4 Konan
108-8241, Tokyo
+
http://www.otsuka.com![address Otsuka Holdings Co., Ltd.(4578)](https://cdn.zonebourse.com/static/address/7997188.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.40% | 23.03B | |
+21.12% | 43.81B | |
+20.88% | 15.45B | |
+19.10% | 14.4B | |
+58.15% | 12.95B | |
-0.05% | 6.79B | |
-11.84% | 6.49B | |
-8.87% | 5.73B | |
+13.00% | 5.49B | |
+9.49% | 4.75B |
- Stock Market
- Equities
- 4578 Stock
- Company Otsuka Holdings Co., Ltd.